Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
- PMID: 2250705
- DOI: 10.1038/348334a0
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Abstract
The t(14; 18) chromosomal translocation of human follicular B-cell lymphoma juxtaposes the bcl-2 gene with the immunoglobulin heavy chain locus. The bcl-2 immunoglobulin fusion gene is markedly deregulated resulting in inappropriately elevated levels of bcl-2 RNA and protein. Transgenic mice bearing a bcl-2 immunoglobulin minigene demonstrate a polyclonal expansion of resting yet responsive IgM-IgD B cells which display prolonged cell survival but no increase in cell cycling. Moreover, deregulated bcl-2 extends the survival of certain haematopoietic cell lines following growth-factor deprivation. By using immunolocalization studies we now demonstrate that Bcl-2 is an integral inner mitochondrial membrane protein of relative molecular mass 25,000 (25k). Overexpression of Bcl-2 blocks the apoptotic death of a pro-B-lymphocyte cell line. Thus, Bcl-2 is unique among proto-oncogenes, being localized to mitochondria and interfering with programmed cell death independent of promoting cell division.
Similar articles
-
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.Nature. 1990 Nov 22;348(6299):331-3. doi: 10.1038/348331a0. Nature. 1990. PMID: 2250704
-
Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death.Semin Cancer Biol. 1993 Dec;4(6):327-32. Semin Cancer Biol. 1993. PMID: 8142617 Review.
-
Bcl-2: an antidote to programmed cell death.Cancer Surv. 1992;15:105-18. Cancer Surv. 1992. PMID: 1451107 Review.
-
Consequences of the t(14;18) chromosomal translocation in follicular lymphoma: deregulated expression of a chimeric and mutated BCL-2 gene.Oncogene Res. 1988 Feb;2(3):263-75. Oncogene Res. 1988. PMID: 3285301
-
Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.Oncogene. 1990 Dec;5(12):1815-9. Oncogene. 1990. PMID: 2284100
Cited by
-
Serum Bcl-2 Levels in Patients with β-Thalassemia Minor: A Pilot Study.Turk J Haematol. 2014 Dec 5;31(4):363-6. doi: 10.4274/tjh.2013.0152. Turk J Haematol. 2014. PMID: 25541652 Free PMC article.
-
Porcine serum can be biofortified with selenium to inhibit proliferation of three types of human cancer cells.J Nutr. 2013 Jul;143(7):1115-22. doi: 10.3945/jn.113.177410. Epub 2013 May 15. J Nutr. 2013. PMID: 23677865 Free PMC article.
-
Potential roles of circulating microRNAs in the healing of type 1 diabetic wounds treated with green tea extract: molecular and biochemical study.Heliyon. 2023 Nov 3;9(11):e22020. doi: 10.1016/j.heliyon.2023.e22020. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027999 Free PMC article.
-
The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak.Mol Cancer. 2013 May 16;12(1):42. doi: 10.1186/1476-4598-12-42. Mol Cancer. 2013. PMID: 23680104 Free PMC article.
-
Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents.Oncotarget. 2016 Jul 19;7(29):46692-46706. doi: 10.18632/oncotarget.8727. Oncotarget. 2016. PMID: 27083002 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
